The United States Prolactin Market was valued at USD 163.8 million in 2024 and is projected to reach USD 246.3 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period (2024–2032). This growth is being driven by rising demand for endocrine diagnostics, increasing prevalence of metabolic disorders, and advancements in reproductive health research across diagnostic laboratories, pharmaceutical companies, and biotechnology sectors.

As the healthcare industry advances toward precision medicine, fertility treatments, and metabolic research, the spotlight is on the key prolactin suppliers who are driving innovation, high-purity production, and reliable diagnostic solutions. In this blog, we profile the Top 10 Companies in the United States Prolactin Industry—a mix of diagnostic giants, biotech leaders, and pharma innovators shaping the future of hormone analysis and endocrine care.

---

🔟 1. Amgen Inc.

Headquarters: Thousand Oaks, California, USA
Key Offering: Recombinant human prolactin, assay standards for research

Amgen Inc. is a biotechnology powerhouse contributing to the prolactin market through its advanced biologics platform. The company supplies high-purity recombinant prolactin for metabolic and endocrine studies, supporting research into hormone roles in insulin regulation and lipid metabolism. Amgen’s focus on protein therapeutics has positioned it as a key player for research institutions exploring prolactin’s links to diabetes and obesity.

With a strong emphasis on precision biologics, Amgen serves academic labs and biotech firms, ensuring products meet FDA standards for stability and bioactivity in sensitive assays.

Diagnostic Initiatives:

• Development of stable recombinant prolactin variants
• Investments in metabolic pathway research
• Collaborations for biomarker discovery

Download FREE Sample Report: United States Prolactin Market – View in Detailed Research Report

---

9️⃣ 2. Eli Lilly and Company

Headquarters: Indianapolis, Indiana, USA
Key Offering: Prolactin research reagents, endocrine diagnostic kits

Eli Lilly and Company plays a vital role in the prolactin space with its endocrine-focused R&D. The company provides prolactin standards and kits for studying hormonal impacts on metabolic disorders, catering to pharmaceutical and research sectors. Lilly’s expertise in hormone therapies extends to prolactin applications in diabetes and fertility studies.

Their products support precise assays in clinical settings, helping diagnose hyperprolactinemia and monitor treatment efficacy.

Diagnostic Initiatives:

• Enhanced purification for high-bioactivity prolactin
• Partnerships in reproductive endocrinology
• Focus on AI-integrated hormone profiling

---

8️⃣ 3. Merck KGaA

Headquarters: Darmstadt, Germany (U.S. operations in Rahway, NJ)
Key Offering: Recombinant human prolactin, biochemical research tools

Through its MilliporeSigma division, Merck KGaA is a leader in supplying recombinant human prolactin for U.S. research labs. The company excels in high-purity proteins for studying prolactin-receptor interactions, vital for fertility and metabolic research. Merck’s innovations support next-gen assays and personalized medicine approaches.

Operating extensively in the U.S., they provide scalable solutions for diagnostic labs facing rising demand for accurate hormone testing.

Diagnostic Initiatives:

• Advanced chromatography purification techniques
• R&D in prolactin for precision diagnostics
• Strategic academic partnerships

---

7️⃣ 4. Bio-Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: Prolactin immunoassay kits, quality controls

Bio-Rad Laboratories is renowned for its immunoassay expertise, offering prolactin test kits essential for endocrine diagnostics. Their products enable high-sensitivity detection in clinical and research settings, aiding in hyperprolactinemia and fertility assessments. Bio-Rad’s commitment to automation supports efficient lab workflows nationwide.

The company’s kits are widely used in hospitals for routine prolactin screening, contributing to early intervention in pituitary disorders.

Diagnostic Initiatives:

• Automated immunoassay advancements
• Quality control standards for prolactin assays
• Expansion in point-of-care testing

Download FREE Sample Report: United States Prolactin Market – View in Detailed Research Report

---

6️⃣ 5. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: Prolactin diagnostic assays, chemiluminescent kits

Abbott Laboratories dominates with cutting-edge prolactin diagnostic kits, leveraging immunoassay technologies for accurate level measurements. Their solutions are integral to fertility clinics and labs diagnosing conditions like prolactinomas. Abbott’s global reach ensures reliable supply for U.S. healthcare providers prioritizing early detection.

Innovations in speed and sensitivity have reduced test times, improving patient outcomes in reproductive health.

Diagnostic Initiatives:

• Chemiluminescent technology integration
• Multiplex hormone panels including prolactin
• FDA-approved advancements for clinical use

---

5️⃣ 6. Pfizer Inc.

Headquarters: New York, New York, USA
Key Offering: Prolactin therapeutics research, diagnostic development

Pfizer Inc. contributes significantly through its hormone-based pharmaceuticals and prolactin research tools. The company supports studies on prolactin in fertility and metabolic therapies, providing reagents for drug discovery. Pfizer’s pipeline addresses hormonal imbalances in IVF and endocrine disorders.

Their strong U.S. presence drives market growth via therapeutic explorations.

Diagnostic Initiatives:

• Hormone diagnostic kit expansions
• R&D in prolactin modulation therapies
• Collaborations with fertility centers

---

4️⃣ 7. Merck & Co., Inc.

Headquarters: Rahway, New Jersey, USA
Key Offering: Endocrine hormone assays, recombinant prolactin

Merck & Co., Inc. advances the prolactin market with integrated endocrine solutions, including assays for hyperprolactinemia diagnostics. Their focus on purification ensures high-quality products for research into metabolic links. Merck’s innovations align with precision medicine demands.

Serving labs across the U.S., they enhance supply chains for stable prolactin forms.

Diagnostic Initiatives:

• Next-gen recombinant technologies
• Broad endocrine therapy integrations
• Investments in diagnostic accuracy

---

3️⃣ 8. Bio-Rad Laboratories, Inc. (wait, duplicate avoided, use Siemens Healthineers US)

Headquarters: Tarrytown, New York, USA (U.S. ops)
Key Offering: Prolactin lab analyzers, immunoassay systems

Siemens Healthineers provides advanced lab systems for prolactin testing, enabling high-throughput diagnostics. Their platforms are used in hospitals for fertility and pituitary evaluations, with emphasis on reliability and integration.

Supporting U.S. labs with automated solutions, they drive efficiency in hormone screening.

Diagnostic Initiatives:

• High-throughput prolactin analyzers
• Digital integration for assays
• Regulatory compliance enhancements

---

2️⃣ 9. Roche Diagnostics

Headquarters: Indianapolis, Indiana, USA (U.S. HQ)
Key Offering: Elecsys prolactin assays, diagnostic platforms

Roche Diagnostics leads with Elecsys systems for ultra-sensitive prolactin measurement, crucial for reproductive health. Their kits support clinical decisions in IVF and endocrine care, backed by extensive validation data.

Roche’s U.S. dominance in immunoassays fuels market expansion.

Diagnostic Initiatives:

• Ultra-sensitive assay developments
• Global standardization efforts
• Reproductive health partnerships

---

1️⃣ 10. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: High-sensitivity prolactin assays, recombinant proteins

Thermo Fisher Scientific Inc. is the market leader in prolactin products, offering comprehensive assays and recombinant proteins for diagnostics and research. Their portfolio powers clinical labs, fertility studies, and metabolic investigations nationwide. Thermo Fisher’s innovation in purification and stability sets industry benchmarks.

With robust U.S. infrastructure, they meet surging demand for precise hormone tools.

Diagnostic Initiatives:

• Comprehensive prolactin assay portfolios
• High-purity recombinant innovations
• End-to-end solutions for labs

Read Full Report: United States Prolactin Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the United States Prolactin Market Is Precision-Driven and Innovative

The United States prolactin market is undergoing a dynamic transformation. While traditional assays dominate, the industry is investing heavily in recombinant technologies, advanced immunoassays, and AI-enhanced diagnostics to meet growing needs in fertility, metabolism, and endocrinology.

📈 Key Trends Shaping the Market:

• Rapid expansion of diagnostic labs in biotech hubs
• Regulatory approvals for multiplex hormone panels
• Digitalization of endocrine testing workflows
• Pharma-lab alliances for research acceleration

Read Full Report: United States Prolactin Market – View in Detailed Research Report

The companies listed above are not only supplying prolactin solutions—they’re spearheading the precision diagnostics revolution in healthcare.